Cargando…
CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients
CD163+ tumor-associated macrophages (TAMs) play an important role in the progression of cancer. However, the significance of CD163+ TAMs in malignant pleural effusion (MPE) is still unclear. The aim of this study is to evaluate the prognostic value of CD163+ TAMs in MPE, and the regulatory effect of...
Autores principales: | Yang, Li, Wang, Fei, Wang, Liping, Huang, Lan, Wang, Jing, Zhang, Bin, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496378/ https://www.ncbi.nlm.nih.gov/pubmed/25871392 |
Ejemplares similares
-
Clinical value of haptoglobin and soluble CD163 testing for the differential diagnosis of tuberculous and malignant pleural effusions
por: Gao, Jinying, et al.
Publicado: (2019) -
Macrophages in malignant pleural effusions – alternatively activated tumor associated macrophages
por: Kaczmarek, Mariusz, et al.
Publicado: (2012) -
Prognostic significance of CD163+ tumor-associated macrophages in colorectal cancer
por: Xue, Tao, et al.
Publicado: (2021) -
Pleural biomarkers in diagnostics of malignant pleural effusion: a narrative review
por: Zhang, Man, et al.
Publicado: (2021) -
Auxiliary diagnostic value of tumor biomarkers in pleural fluid for lung cancer-associated malignant pleural effusion
por: Zhang, Hai, et al.
Publicado: (2020)